Research into GLP-1 medicines is expanding beyond diabetes and weight management, with scientists investigating their potential effects on mental health, addiction and brain function.
Talking Medicines has highlighted the emerging research surrounding glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medicines that includes treatments used for type 2 diabetes and obesity. The findings are prompting further investigation into how these drugs may influence processes linked to mood, reward, appetite and behaviour.
GLP-1 medicines work by mimicking the action of a naturally occurring hormone involved in blood glucose regulation and appetite. Researchers are now exploring whether these biological pathways could also have relevance to conditions such as depression, substance use disorders and other psychiatric conditions.
One area attracting attention is addiction. Clinical research has reported that semaglutide may reduce alcohol cravings and episodes of heavy drinking in people with alcohol use disorder. These findings have encouraged further studies into whether GLP-1-based treatments could offer an additional approach to managing substance-related conditions.
Researchers are also examining possible benefits for people with serious mental illnesses. Recent observational findings have linked GLP-1 treatment with lower rates of psychiatric hospital admissions among people with schizophrenia and type 2 diabetes. However, these results do not establish that the medicines directly treat schizophrenia or prevent psychiatric crises.
The potential relationship between GLP-1 medicines and mental health is complex. The drugs can improve metabolic health, which may be particularly relevant for people taking psychiatric medicines associated with weight gain and an increased risk of diabetes. Researchers are also investigating whether GLP-1 signalling has more direct effects on brain systems involved in reward, motivation and emotional regulation.
Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.
